The Enterprise Value as of December 2024 (TTM) for Agile Therapeutics, Inc. (AGRX) is 7.87M

According to Agile Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 7.87M. This represents a change of 72.19% compared to the average of 4.57M of the last 4 quarters.

Agile Therapeutics, Inc. (AGRX) Historical Enterprise Value (quarterly & annually)

How has AGRX Enterprise Value performed in the past?

The mean historical Enterprise Value of Agile Therapeutics, Inc. over the last ten years is 77.87M. The current 7.87M Enterprise Value has changed 910.24% with respect to the historical average. Over the past ten years (40 quarters), AGRX's Enterprise Value was at its highest in in the December 2017 quarter at 184.13B. The Enterprise Value was at its lowest in in the March 2024 quarter at -986386.46.

Agile Therapeutics, Inc. (AGRX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Agile Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Agile Therapeutics, Inc. (AGRX) Average Enterprise Value

How has AGRX Enterprise Value performed in the past?

The current Enterprise Value of Agile Therapeutics, Inc. (AGRX) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Agile Therapeutics, Inc. (AGRX) Enterprise Value vs. Peers

How is AGRX’s Enterprise Value compared to its peers?

Agile Therapeutics, Inc.’s Enterprise Value is less than Assertio Holdings, Inc. (84.08M), less than Amneal Pharmaceuticals, Inc. (6.18B), greater than AcelRx Pharmaceuticals, Inc. (-575925.00), less than Lifecore Biomedical, Inc. (406.81M), greater than Guardion Health Sciences, Inc. (-10475955.00), less than Alpha Teknova, Inc. (489.28M), less than Cyclo Therapeutics, Inc. (16.39M), greater than Petros Pharmaceuticals, Inc. (6.23M), greater than Shuttle Pharmaceuticals Holdings, Inc. (3.30M), less than Mallinckrodt plc (2.67B), less than Athenex, Inc. (9.07M), greater than Evoke Pharma, Inc. (1.08M), less than Cumberland Pharmaceuticals Inc. (39.12M), greater than PainReform Ltd. (-24885.00), less than Aquestive Therapeutics, Inc. (277.64M),

Build a custom stock screener for Agile Therapeutics, Inc. (AGRX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Agile Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Agile Therapeutics, Inc. (AGRX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Agile Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.